Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2017, Article ID 9653793, 10 pages
https://doi.org/10.1155/2017/9653793
Research Article

Toll-Like Receptor Ligand-Induced Liver Injury in D-Galactosamine-Sensitized Mice: Differences between TLR7/8 and TLR9 Ligands, Cytokine Patterns, and Cross-Tolerance Induction by TLR2 Ligand Pretreatment

Teikyo University School of Medical Technology, Itabashi, Tokyo, Japan

Correspondence should be addressed to Reiko Seki; pj.ca.u-oykiet.dem@kyh

Received 28 March 2017; Revised 10 August 2017; Accepted 13 September 2017; Published 17 October 2017

Academic Editor: Xiao-Feng Yang

Copyright © 2017 Reiko Seki. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. Galanos, M. A. Freudenberg, and W. Reutter, “Galactosamine-induced sensitization to the lethal effects of endotoxin,” Proceedings of the National Academy of Sciences of the United States of America, vol. 76, no. 11, pp. 5939–5943, 1979. View at Publisher · View at Google Scholar
  2. W. Jiang, R. Sun, H. Wei, and Z. Tian, “Toll-like receptor 3 ligand attenuates LPS-induced liver injury by down-regulation of toll-like receptor 4 expression on macrophages,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 47, pp. 17077–17082, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Mignon, N. Rouquet, M. Fabre et al., “LPS challenge in D-galactosamine-sensitized mice accounts for caspase-dependent fulminant hepatitis, not for septic shock,” American Journal of Respiratory and Critical Care Medicine, vol. 159, no. 4, Part 1, pp. 1308–1315, 1999. View at Publisher · View at Google Scholar
  4. M. Nowak, G. C. Gaines, J. Rosenberg et al., “LPS-induced liver injury in D-galactosamine-sensitized mice requires secreted TNF-α and the TNF-p55 receptor,” American Journal of Physiology - Regulatory, Integrative and Comparative Physiology, vol. 278, no. 5, pp. 1202–1209, 2000. View at Google Scholar
  5. R. F. Stachlewitz, V. Seabra, B. Brandford et al., “Glycine and uridine prevent D-galactosamine hepatotoxicity in the rat: role of Kupffer cells,” Hepatology, vol. 29, pp. 737–745, 1999. View at Publisher · View at Google Scholar
  6. A. K. Yi, H. Yoon, J. E. Park, B. S. Kim, H. J. Kim, and A. Martinez-Hernandez, “CpG DNA-mediated induction of acute liver injury in D-galactosamine-sensitized mice: the mitochondrial apoptotic pathway-dependent death of hepatocytes,” Journal Biological Chemistry, vol. 281, no. 21, pp. 15001–15012, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. L. Dejager and C. Libert, “Tumor necrosis factor alpha mediates the lethal hepatotoxic effects of poly(I:C) in D-galactosamine-sensitized mice,” Cytokine, vol. 42, no. 1, pp. 55–61, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Dunne, N. A. Marshall, and K. H. Mills, “TLR based therapeutics,” Current Opinion in Pharmacology, vol. 11, no. 4, pp. 404–411, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Teixeira-Coelho, A. Cruz, J. Carmona et al., “TLR2 deficiency by compromising p19 (IL-23) expression limits Th17 cell responses to mycobacterium tuberculosis,” International Immunology, vol. 23, no. 2, pp. 89–96, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. C. X. Lima, D. G. Souza, F. A. Amaral et al., “Therapeutic effects of treatment with anti-TLR2 and anti-TLR4 monoclonal antibodies in polymicrobial sepsis,” PLoS One, vol. 10, no. 7, article e0132336, 2015. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Gao, Z. Jiang, S. Wang, Y. Zhou, X. Shi, and M. Feng, “Endoplasmic reticulum stress of Kupffer cells involved in the conversion of natural regulatory T cells to Th17 cells in liver ischemia-reperfusion injury,” Journal of Gastroenterology and Hepatology, vol. 31, no. 4, pp. 883–889, 2016. View at Publisher · View at Google Scholar · View at Scopus
  12. A. Shimamoto, A. J. Chong, M. Yada et al., “Inhibition of Toll-like receptor 4 with eritoran attenuates myocardial ischemia-reperfusion injury,” Circulation, vol. 114, no. 1, pp. I270–I274, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. S. B. Anderberg, T. Luther, and R. Frithiof, “Physiological aspects of Toll-like receptor 4 activation in sepsis-induced acute kidney injury,” Acta Physiologica, vol. 219, no. 3, pp. 573–588, 2016. View at Publisher · View at Google Scholar · View at Scopus
  14. M. S. Duthie, H. P. Windish, C. B. Fox, and S. G. Reed, “Use of defined TLR ligands as adjuvants within human vaccines,” Immunological Reviews, vol. 239, no. 1, pp. 178–196, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. G. Trinchieri and A. Sher, “Cooperation of Toll-like receptor signals in innate immune defense,” Nature Reviews Immunology, vol. 7, no. 3, pp. 179–190, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. R. Anuradha, K. Chakraborty, and P. Ray, “Immunosuppressive MDSCs induced by TLR signaling during infection and role in resolution of inflammation,” Frontiers in Cellular and Infection Microbiology, vol. 3, p. 52, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. M. A. Dobrovolskaia, A. E. Medvedev, K. E. Thomas et al., “Induction of in vitro reprogramming by toll-like receptor (TLR)2 and TLR4 agonists in murine macrophages: effects of TLR “homotolerance” versus “heterotolerance” on NF-κB signaling pathway components,” The Journal of Immunology, vol. 170, no. 1, pp. 508–519, 2003. View at Publisher · View at Google Scholar
  18. M. I. Arshad, S. Patrat-Delon, C. Piquet-Pellorce et al., “Pathogenic mouse hepatitis virus or poly(I:C) induce IL-33 in hepatocytes in murine models of hepatitis,” PLoS One, vol. 8, no. 9, article e74278, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. N. Kuroda, K. Inoue, T. Ikeda, Y. Hara, K. Wake, and T. Sato, “Apoptotic response through a high mobility box 1 protein-dependent mechanism in LPS/GalN-induced mouse liver failure and glycyrrhizin-mediated inhibition,” PLoS One, vol. 9, no. 4, article e92884, 2014. View at Publisher · View at Google Scholar · View at Scopus
  20. Charles river, “Control data of each strain,” 2017. View at Google Scholar
  21. M. E. Bianch, “DAMPs, PAMPs and alarmins: all we need to know about danger,” Journal of Leukocyte Biology, vol. 81, no. 1, pp. 1–5, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. R. Jacinto, T. Hartung, C. McCall, and L. Li, “Lipopolysaccharide- and lipoteichoic acid-induced tolerance and cross-tolerance: distinct alterations in IL-1 receptor-associated kinase,” The Journal of Immunology, vol. 168, no. 12, pp. 6136–6141, 2002. View at Publisher · View at Google Scholar
  23. S. Sato, F. Nomura, T. Kawai et al., “Synergy and cross-tolerance between toll-like receptor (TLR) 2- and TLR4-mediated signaling pathways,” The Journal of Immunology, vol. 165, no. 12, pp. 7096–7101, 2000. View at Publisher · View at Google Scholar
  24. S. Furuya, H. Kono, M. Hara, K. Hirayama, C. Sun, and H. Fujii, “Interleukin 17A plays a role in lipopolysaccharide/D-galactosamine-induced fulminant hepatic injury in mice,” Journal of Surgical Research, vol. 199, no. 2, pp. 487–493, 2015. View at Publisher · View at Google Scholar · View at Scopus
  25. J. D. Turner, R. S. Langley, K. L. Johnston et al., “Wolbachia endosymbiotic bacteria of Brugia malayi mediate macrophage tolerance to TLR- and CD40-specific stimuli in a MyD88/TLR2-dependent manner,” The Journal of Immunology, vol. 177, no. 2, pp. 1240–1249, 2006. View at Publisher · View at Google Scholar
  26. S. Manicassamy, R. Ravindran, J. Deng et al., “Toll-like receptor 2-dependent induction of vitamin A-metabolizing enzymes in dendritic cells promotes T regulatory responses and inhibits autoimmunity,” Nature Medicine, vol. 15, no. 4, pp. 401–409, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. T. Kondo, T. Kawai, and S. Akira, “Dissecting negative regulation of Toll-like receptor signaling,” Trends in Immunology, vol. 33, no. 9, pp. 449–458, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. K. Nakayama, S. Okugawa, S. Yanagimoto et al., “Involvement of IRAK-M in peptidoglycan-induced tolerance in macrophages,” Journal of Biological Chemistry, vol. 279, no. 8, pp. 6629–6634, 2004. View at Publisher · View at Google Scholar · View at Scopus
  29. Y. Xiong, M. Pennini, S. N. Vogel, and A. E. Medvedev, “IRAK4 kinase activity is not required for induction of endotoxin tolerance but contributes to TLR2-mediated tolerance,” Journal of Leukocyto Biology, vol. 94, no. 2, pp. 291–300, 2013. View at Publisher · View at Google Scholar · View at Scopus
  30. R. Nakagawa, T. Naka, H. Tsutsui et al., “SOCS-1 participates in negative regulation of LPS responses,” Immunity, vol. 17, no. 5, pp. 677–687, 2002. View at Publisher · View at Google Scholar · View at Scopus
  31. A. Mansell, R. Smith, S. L. Doyle et al., “Suppressor of cytokine signaling 1 negatively regulates Toll-like receptor signaling by mediating Mal degradation,” Nature Immunology, vol. 7, no. 2, pp. 148–155, 2006. View at Publisher · View at Google Scholar · View at Scopus
  32. J. M. Otte, E. Cario, and D. K. Podolsky, “Mechanisms of cross hyporesponsiveness to Toll-like receptor bacterial ligands in intestinal epithelial cells,” Gastroenterology, vol. 126, no. 4, pp. 1054–1070, 2004. View at Publisher · View at Google Scholar · View at Scopus
  33. D. L. Boone, E. E. Turer, E. G. Lee et al., “The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses,” Nature Immunology, vol. 5, no. 10, pp. 1052–1060, 2004. View at Google Scholar
  34. O. Ananieva, J. Darragh, C. Johansen et al., “The kinases MSK1 and MSK2 act as negative regulators of Toll-like receptor signaling,” Nature Immunology, vol. 9, no. 9, pp. 1028–1036, 2008. View at Publisher · View at Google Scholar · View at Scopus
  35. S. Mukhopadhyay, A. Plüddemann, J. C. Hoe et al., “Immune inhibitory ligand CD200 induction by TLRs and NLRs limits macrophage activation to protect the host from meningococcal septicemia,” Cell Host & Microbe, vol. 8, no. 3, pp. 236–247, 2010. View at Publisher · View at Google Scholar · View at Scopus
  36. P. E. Almeida, A. R. Silva, C. M. Maya-Monteiro et al., “Mycobacterium bovis Bacillus Calmette-Guérin infection induces TLR2-dependent peroxisome proliferator-activated receptor γ expression and activation: functions in inflammation, lipid metabolism, and pathogenesis,” The Journal of Immunology, vol. 183, no. 2, pp. 1337–1345, 2009. View at Publisher · View at Google Scholar · View at Scopus
  37. R. Seki and K. Nishizawa, “Factors regulating Th17 cells: a review,” Biomedical Research and Clinical Practice, vol. 1, no. 4, pp. 126–147, 2016. View at Publisher · View at Google Scholar
  38. M. A. Nahid, K. M. Pauley, M. Satoh, and E. K. Chan, “miR-146a is critical for endotoxin-induced tolerance: IMPLICATION IN INNATE IMMUNITY,” The Journal of Biological Chemistry, vol. 284, no. 50, pp. 34590–34599, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. E. M. Quinn, J. H. Wang, G. O'Callaghan, and H. P. Redmond, “MicroRNA-146a is upregulated by and negatively regulates TLR2 signaling,” PLoS One, vol. 8, no. 4, article e62232, 2013. View at Publisher · View at Google Scholar · View at Scopus
  40. R. M. O'Connell, K. D. Taganov, M. P. Boldin, G. Cheng, and D. Baltimore, “MicroRNA-155 is induced during the macrophage inflammatory response,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 5, pp. 1604–1609, 2007. View at Publisher · View at Google Scholar · View at Scopus
  41. Y. Li and X. Shi, “MicroRNAs in the regulation of TLR and RIG-I pathways,” Cellular and Molecular Immunology, vol. 10, no. 1, pp. 65–71, 2013. View at Publisher · View at Google Scholar · View at Scopus
  42. M. A. Nahid, B. Yao, P. R. Dominguez-Gutierrez, L. Kesavalu, M. Satoh, and E. K. Chan, “Regulation of TLR2-mediated tolerance and cross-tolerance through IRAK4 modulation by miR-132 and miR-212,” The Journal of Immunology, vol. 190, no. 3, pp. 250–1263, 2013. View at Publisher · View at Google Scholar · View at Scopus
  43. A. Boonstra, R. Rajsbaum, M. Holman et al., “Macrophages and myeloid dendritic cells, but not plasmacytoid dendritic cells, produce IL-10 in response to MyD88- and TRIF-dependent TLR signals, and TLR-independent signals,” The Journal of Immunology, vol. 177, no. 11, pp. 7551–7558, 2006. View at Publisher · View at Google Scholar
  44. J. Lee, J. H. Mo, K. Katakura et al., “Maintenance of colonic homeostasis by distinctive apical TLR9 signaling in intestinal epithelial cells,” Nature Cell Biology, vol. 8, no. 12, pp. 1327–1336, 2006. View at Publisher · View at Google Scholar · View at Scopus
  45. A. H. Dalpke, M. D. Lehner, T. Hartung, and K. Heeg, “Differential effects of CpG-DNA in toll-like receptor-2/-4/-9 tolerance and cross-tolerance,” Immunology, vol. 116, no. 2, pp. 203–212, 2005. View at Publisher · View at Google Scholar · View at Scopus
  46. T. Liu, T. Matsuguchi, N. Tsuboiet, T. Yajima, and Y. Yoshikai, “Differences in expression of Toll-like receptors and their reactivities in dendritic cells in BALB/c and C57BL/6 mice,” Infection and Immunity, vol. 7, no. 12, pp. 6638–6645, 2002. View at Publisher · View at Google Scholar · View at Scopus
  47. D. Stewart, W. B. Fulton, C. Wilson et al., “Genetic contribution to the septic response in a mouse model,” Shock, vol. 18, no. 4, pp. 342–347, 2002. View at Publisher · View at Google Scholar
  48. C. S. Hsieh, S. E. Macatonia, A. O'Garra, and K. M. Murphy, “T cell genetic background determines default T helper phenotype development in vitro,” The Journal of Experimental Medicine, vol. 181, no. 2, pp. 713–721, 1995. View at Publisher · View at Google Scholar · View at Scopus
  49. C. D. Mills, K. Kincaid, J. M. Alt, M. J. Heilman, and A. M. Hill, “M-1/M-2 macrophages and the Th1/Th2 paradigm,” The Journal of Immunology, vol. 164, no. 12, pp. 6166–6173, 2000. View at Publisher · View at Google Scholar
  50. E. Kuroda and U. Yamashita, “Mechanisms of enhanced macrophage-mediated prostaglandin E2 production and its suppressive role in Th1 activation in Th2-dominant BALB/c mice,” The Journal of Immunology, vol. 170, no. 2, pp. 757–764, 2003. View at Publisher · View at Google Scholar
  51. E. Kuroda, T. Kito, and U. Yamashita, “Reduced expression of STAT4 and IFN-γ in macrophages from BALB/c mice,” The Journal of Immunology, vol. 168, no. 11, pp. 5477–5482, 2002. View at Publisher · View at Google Scholar
  52. H. Watanabe, K. Numata, T. Ito, K. Takagi, and A. Matsukawa, “Innate immune response in Th1- and Th2-dominant mouse strains,” Shock, vol. 22, no. 5, pp. 460–466, 2004. View at Publisher · View at Google Scholar · View at Scopus